Small caps round-up: Cello, DDD, Kewill...

This round-up also covers: Pennant International Group, Active Energy, ValiRx, Angel Biotechnology, and Pennant International Group.

Marketing firm Cello Group has reported good trading during the first three months of the year, reflecting 'the strong pipeline of work secured at the end of 2011 and a solid flow of bookings'.

The research and consulting division was a strong performer, while the group's focus on the pharmaceuticals research market, continues to pay off. Pharma is an area in which the group continues to expand, with a focus on international markets and particularly the US market where the group is planning to invest further. A 'notable improvement' in profitability was seen during the quarter, and the forward pipeline of work is 'solid', the firm said, adding the it remains optimistic that full year expectations will be met.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.